FDDA Utilization Study (FDDAU)
Not Applicable
Terminated
- Conditions
- Fatigue
- Interventions
- Other: Fatigue Differential Diagnosis Aid
- First Posted Date
- 2023-05-17
- Last Posted Date
- 2023-05-17
- Lead Sponsor
- Vifor Pharma, Inc.
- Target Recruit Count
- 217
- Registration Number
- NCT05861492
- Locations
- ๐จ๐ญ
QualiPro Schweiz AG, Kriens, Luzern, Switzerland
Patiromer for Treatment of Hyperkalaemia in Children Under 12 Years of Age
- First Posted Date
- 2023-03-13
- Last Posted Date
- 2025-03-27
- Lead Sponsor
- Vifor Pharma, Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT05766839
- Locations
- ๐ซ๐ท
CHRU Montpellier - Arnaud de Villeneuve, Montpellier, France
๐ซ๐ทAssistance Publique-Hopitaux de Paris - Hopital Universitaire Robert-Debre, Paris, France
๐ฎ๐ฑSchneider Children's Medical Center of Israel, Petach Tikvah, Israel
Patiromer for the Management of Hyperkalemia in Subjects Receiving RAASi Medications for the Treatment of Heart Failure (DIAMOND)
- First Posted Date
- 2019-03-25
- Last Posted Date
- 2023-02-24
- Lead Sponsor
- Vifor Pharma, Inc.
- Target Recruit Count
- 1195
- Registration Number
- NCT03888066
- Locations
- ๐บ๐ธ
Investigator Site 11-088, Haddon Heights, New Jersey, United States
๐บ๐ธInvestigator Site 11-148, New Brunswick, New Jersey, United States
๐บ๐ธInvestigator Site 11-054, Linden, New Jersey, United States
Pharmacodynamic & Safety of Patiromer in Children & Adolescents (2-<18 Yrs) With Chronic Kidney Disease and Hyperkalemia
- First Posted Date
- 2017-03-22
- Last Posted Date
- 2022-10-19
- Lead Sponsor
- Vifor Pharma, Inc.
- Target Recruit Count
- 23
- Registration Number
- NCT03087058
- Locations
- ๐บ๐ธ
Investigator Site 1101, Kansas City, Kansas, United States
๐ง๐ฌInvestigator Site 1401, Sofia, Bulgaria
๐ต๐ฑInvestigator Site 5404, Gdansk, Poland
ยฉ Copyright 2025. All Rights Reserved by MedPath